chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 32 hours after second dose of Moderna vaccine a fever developed. Ranging from 99-102 over a period of two hours.  Accompanied by chills and slight headache. Took 3 extra strength Tylenol went to bed and woke up the following morning feeling normal.  Approximately 48 hours after vaccine discovered a somewhat large (nickel sized) lump in the neck region above my collarbone on the left side (some side as injection) . Tender to touch. Still present to this point. Arm soreness continues but is getting better.
This spontaneous report as received from a healthcare worker refers to a 10-year-old patient of unknown gender. The patient's concurrent conditions and medical history were not reported. On 19-OCT-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (lot # reported as L011846, expiration date was reported as 16-JUN-2015) (dose, route and site of administration were not provided). Concomitant medications were not reported. No adverse effects was reported. This is one of several reports from the same source. Additional information has been requested.
08:55 PATIENT COMPLAINS THROAT SORENESS AND TIGHTNESS. PATIENT DENIES ANY INCREASE IN WORK OF BREATHING. VITALS ARE 115/78 BP, HR 76, RESP RATE 18, O2SAT 98%. LUNGS CLEAR AND WILL MONITOR ANOTHER 15 MINS.  0:920 AGTER ADDITIONSL 15 MINS OF OBSERVATION PATIENT HAS NO WORENING OF SYMPTOMS NOTED AND STATES NO SHORTNESS OF BREATH OR CHEST TIGHTNESS. PATIENT RELEASED TO GO AND INSTRUCTED TO FOLLOW-UP WITH EMERGENCY DEPARTMENT IF SYMPTOMS RE-OCCUR OR GET WORSE.
Throat tightness and dryness, facial tingling. After 10 minutes, persistent and worsening throat tightness, facial tingling. Given Epipen and albuterol. Sent to ED.
Patient reported an unusually dry throat 15 minutes after vaccine. She was given water and her observation period was extended. At 30 minutes after vaccination she reported a lump in her throat and felt a strange sensation when swallowing.  She was given diphenhydramine 50mg IM in right deltoid. She then experienced  dizziness, nausea, chills and was visibly shaky. She was observed for about 90 minutes and we discussed the best option was for the EMS squad to evaluate her. Upon follow up at 8pm she was drowsy, shaky, and still had the lump in her throat . She had opted not to be transported to the hospital after EMS evaluated her in the ambulance.  Her husband came into store at 8:30 pm to get  diphenhydramine in oral form which I had suggested she take for the next 24-48 hours.  On 9/4/21 I spoke with patient around 2pm and the lump in her throat had decreased and she was still taking diphenhydramine.
This spontaneous report was received from a physician via company representative refers to a 2 year old patient. On an unknown date, the patient was vaccinated with an adult dose of VAQTA, (lot number, expiry date and route was not reported). Concomitant medications were not reported. No adverse effect was reported. Additional information has been requested.
Febrile seizure - 5 minutes - fever 106 degrees F - chest X Ray, EEG - Brain ultrasound - Normal ventricular size.
Patient was vaccinated with Fluad-Left arm and Shingrix-right arm on 8/15/19. She presented to the pharmacy on 8/20/19 stating that I tried to hurt her and she knows what I did. She stated that she would put it on social media so everyone would know. I apologized that she felt that way and told her I would not try to hurt her. I tried to get info from her to see if she was having any adverse rxn, but she wasn't interested in giving me info and she just left. There is no real adverse rxn to report other that pain after fluad administration. She did state in way the flu shot, but no sure it that is accurate. Employer wants this reported on VAERS.
rash on both of her legs and back; one leg looks like a mosquito bite with hives around it; one leg looks like a mosquito bite with hives around it; she also had a patch on her back; This is a spontaneous report from a contactable consumer (reported for herself) via Medical information team.  A 72-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration on 08Apr2021 (at the age of 72-years) as SINGLE DOSE for covid-19 immunization. Medical history included: lot of drug allergies and to antibiotics. The patient's concomitant medications were not reported. On an unspecified date in Apr2021, the patient experienced a rash on both of her legs and back. The rash looks like if blood was to come to the top of the skin and it has dots around the rash. Also reported that one leg looks like a mosquito bite with hives around it and she also had a patch on her back. She was scheduled for the second dose tomorrow and would like to know if she should receive it. She had a lot of drug allergies and to antibiotics that she was afraid she might have a worse reaction with dose two. Caller reported that when she takes the flu shot she has to take it in two doses instead of one seven days apart at a hospital due to her allergy. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
4/28/2021@12:30pm noticed rash on left side of neck rash and swelling began to appear on left side of face.Called  health department and was told they had no doctor to help me.4/29/2021 went to ER where I was given benadryl and a perscription.
Vaccines administered in Quad muscle not vastus lateralis. 1 of the two vaccines had 3 injection sites unknown which of the two. Localized reaction of rednes, swelling at injection sites, minor nerve damage expect to resolve over the next several days. Not bearing full weight on left leg. Left leg turned inward.
feels itchy, feet, legs and lower back itch after getting out of the shower; little red spots on arms; knees feel like on fire and red in color; knees feel like on fire and red in color; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (feels itchy, feet, legs and lower back itch after getting out of the shower), RASH MACULAR (little red spots on arms), ERYTHEMA (knees feel like on fire and red in color) and ARTHRALGIA (knees feel like on fire and red in color) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hives. Concurrent medical conditions included Sensitive skin.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (feels itchy, feet, legs and lower back itch after getting out of the shower), RASH MACULAR (little red spots on arms), ERYTHEMA (knees feel like on fire and red in color) and ARTHRALGIA (knees feel like on fire and red in color). At the time of the report, PRURITUS (feels itchy, feet, legs and lower back itch after getting out of the shower), RASH MACULAR (little red spots on arms), ERYTHEMA (knees feel like on fire and red in color) and ARTHRALGIA (knees feel like on fire and red in color) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Information has been received from a 60 year old female patient with spinal stenosis, pinched nerve and kidney stones referring to herself. On 29-SEP-2015 the patient was vaccinated with ZOSTAVAX (1 shot, lot number was unknown) intramuscularly. There was no concomitant medication. On 12-OCT-2015 (also reported as 12-AUG-2015) at 8:30 pm the patient experienced strong itch on neck, she could not stop scratching. In addition, her right cheek was swelling and gum on bottom of mouth was numb and tingling. She stated that the swelling on her right cheek was the size of a golf ball cut in half. She was very nervous about the adverse reaction. She became pale with discolored lips from adverse reaction. In addition, she was blotchy at the injection site. She was taken to the emergency room (ER) on 12-OCT-2015. The patient was administered an intravenous (IV) with "PEPSID", BENADRYL, and "PREGNOZONE". Furthermore, in October 2015 at hospital in a doctor office the patient had a computerised axial tomogram (CAT) scan to check for an abscess tooth. She was sneezing a lot (in 2015). Test results proved that she had mucus in nasal cavity. Since adverse reaction swelling had gone down significantly. Color had come back in her face. Patient still had puffiness in cheek. She mentioned BENADRYL made her sleepy (in October 2015). She stated that it put her out like a light and was snoring. The outcome of the events (except for pale) was reported as recovering. The causality was not reported. Upon internal review, intravenously with BENADRYL for itch on neck, cheek swelling, gum numb and tingling, pale, discolored lips and injection site blotchy was considered to be medically significant. Additional information has been requested.
Patient was administered COVID Vaccine (Moderna). Patient's age is 17 years 4 months.
Patient presented to a prenatal appt on October 27th, 2022.  Patient received a flu  vaccine at appt.  System flagged a duplicate vaccine.  When this nurse checked System patient had received a flu vaccine at Pharmacy on October 13th, 2022.  Patient received two flu vaccines in a two week period of time.  Patient's EGA on October 27th was 37 weeks 3 days with EDD 11/14/2022.  No adverse reactions noted.
Adult patient received Monovalent vaccine 1 day after MFG expiration date; No adverse event; Patient received Monovalent vaccine after MFG expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Monovalent vaccine after MFG expiration date), PRODUCT STORAGE ERROR (Adult patient received Monovalent vaccine 1 day after MFG expiration date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 033K21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 21-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Monovalent vaccine after MFG expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Adult patient received Monovalent vaccine 1 day after MFG expiration date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Monovalent vaccine after MFG expiration date), PRODUCT STORAGE ERROR (Adult patient received Monovalent vaccine 1 day after MFG expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received Monovalent vaccine after MFG expiration date) and PRODUCT STORAGE ERROR (Adult patient received Monovalent vaccine 1 day after MFG expiration date).    Pharmacist was calling to report that 8 adult patients received Moderna COVID-19 vaccine beyond manufacture expiration date. No concomitant medications were reported. MFG Expiration date was 20May2022 (agent checked, it had not been extended). It was unbroken cartons. Vial size was reported as 5.5 ml. The vial was initially stored in the refrigerator on 20-MAY-2022 and 28-MAY-2022 The vaccine was administered to 4 adult patients on 21-MAY-2022 and 4 more adult patients on 29-MAY-2022 The vial did not underwent any temperature excursions. No treatment medications were reported. This case contains information for the 3rd of 8 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-679408, US-MODERNATX, INC.-MOD-2022-679413, US-MODERNATX, INC.-MOD-2022-679412 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-679408:same reporter US-MODERNATX, INC.-MOD-2022-679412:same reporter US-MODERNATX, INC.-MOD-2022-679413:same reporter
Patient reported to clinic for Typhoid Immunization on 1/9/2014 and stated that he had already received the vaccination numerous times recently. Upon pulling the electronic record, it was found that the initial record of immunization given Feb 2013 for oral typhoid was documented as only the first pill being given. Subsequently causing the patient to populate on the Medical Readiness Reporting System (MRRS) as needing to complete the rest of the oral series although already complete. Patient then returned to the clinic on 12/3/2013 at which time the vaccinator administered injectable typhoid vaccination. When the 12/3/2013 vaccine was documented in the MRRS, it was documented as the 2nd pill in the oral series in turn causing the patient to again remain on the readiness hit list. Patient has had no adverse reation or side effects noted.
Patient describes having severe pain in injection site a few days following vax. The patient did see her PCP who prescribe ALEVE an anti-inflammatory drug. Patient is not sure of exact date vax given but it was received mid Sept. 09. Follow-up Information 19-JAN-2010: Per patient she do not know the exact date of vax and adverse event onset date, and to please contact her doctor to obtain this info.
Client received immunizations on 3/2/2016. She stated that her arm has been painful since the injection. When she arrived at the office on 4/20/2016 there was a visible lump in her arm about 20mm in diameter. She scheduled an appointment with her PCP.
EXTREMELY itchy legs. I could have torn my skin off. Attempt to alleviate left bruises. It lasted for 2 weeks. Used topical and oral Benadryl with some relief.
I contracted COVID on 05/25/2022, I woke up with severe headache, chills and body ache. I felt terrible. I might have had a fever, but I took Tylenol before going to the clinic. I followed by the next day lost my taste and smell I was very tired and fatigued. I am now a week out, this shakiness and fatigued is beyond belief. I think I need a few more days. I was too old to get the medication for the COVID, says my NP.
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not received 1st and 2nd Moderna doses but received a Moderna booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not received 1st and 2nd Moderna doses but received a Moderna booster). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Did not received 1st and 2nd Moderna doses but received a Moderna booster) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  There were no vaccine records reported on the state website for the patient and the pharmacy had no records of ever giving the vaccine to the patient and the patient received a booster. Now months later the manager indicates they thought the patient had 1st and 2nd Moderna dose but in reality, they never did so they are requesting to give 1st and 2nd Moderna doses.
pt recvd vax & Lt Arm became paralysed,could not move for 5-6 hrs;h/a top of head persists p/24 hrs;advised to MD or er;exp pain at inject site;pain lt neck,Lt pectoral area plus rapid heart beat;c/o only h/a;dx acute anxiety rxn post injec
Information has been received from a male physician who in 1997 and 1998 was vaccinated with a first and second dose of varicella vaccine. After the immunications, the physician had a positive titer. It was reported on 08/17/2001 that "now" he has no detectable titer. The physician did not seek medical attention. Additional info has been requested.
fever to 100.4 and vomiting. (L) upper arm red, swollen, warm to touch area circled with pen-father will watch, cool compress. Will recheck tomorrow if needed
Right anterior thigh with papule at site of injection leg medial and distal to site red and warm, not tender.
While waiting 15 min. following vaccine administration in clinic waiting room per clinic protocol, pt. began experiencing numbness and tingling in arm where vaccine was administered. Symptoms went down patient's arm into hand/fingers. Pt. declined need for medical attention at the hospital and reported she just wanted to return home. Encouraged pt. to call HCP with any further symptoms or worsening of numbness/tingling. Pt. left clinic. Follow-up phone call made to patient in afternoon at approx. 1520 (01/21/2021). Pt. reported that symptoms had resolved at time of follow-up phone call and denied further need for medical attention.
Client was given his Moderna vaccine and he had made it to the observation area and sat down. He then fell out of his chair onto the floor. At the time I saw the client he was laying face down on the floor, head twitching and body jerking slightly. Shortly after he roused and turned on left side. He was then examined an RN. His vitals were taken every 15 minutes until he was able to sit up. He stated that the left side of his face and eye started twitching and he blacked out. He then fell out of his chair. He had a 2cm raised area to his left forehead and was advised to seek medical treatment. He was examined by the emergency medical staff that was called.  He refused to be transported to the er by ambulance. He was sent home with family after being able to sit up and eat
Employee states that 20 mins after receiving vaccine he noticed a metallic taste. As well his face turned red. He stated he had a tingling sensation that started on his face and descended down his body to his knees, then ascended back to his face. Employee states he took BENADRYL.
Fever (100.4), chills, nausea  and severe joint and body aches
polymyalgia rheumatica; mild headache; upper arm and hip flexor ache; upper arm and hip flexor ache; injection site induration; left arm muscle ache; malaise; This is a spontaneous report from a contactable physician reporting for self. A 72-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot #EL3249), via an unspecified route of administration on 23Jan2021 12:00 at single dose for covid-19 immunisation. Medical history included hypertension, arthritis.  Concomitant medication included losartan, hctz, dabigatran. On 23Jan2021, patient experienced injection site induration, left arm muscle ache, malaise; on 30Jan2021, patient experienced mild headache, upper arm and hip flexor ache relieved by aspirin or NSAIDs for three days, and polymyalgia rheumatica. Consistent with polymyalgia rheumatica. Still the same symptoms at day 12 the milder. Outcome of events was recovering.; Sender's Comments: The serious event reported as polymyalgia rheumatica is deemed as possibly related to BNT162B2 vaccine administration based on the plausible drug-event temporal association  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Head hurting - constant achiness; received other vaccine on 20Jan2021 on the left arm; This is a spontaneous report from a contactable consumer (patient). This 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021 10:00 at single dose on the left arm for COVID-19 immunization. The patient medical history included allergies: Milk. Patient took migraine medications in two weeks. Facility type vaccine was hospital. Patient was not pregnant. The patient received other vaccine on 20Jan2021 on the left arm. The patient experienced head hurting - constant achiness on 20Jan2021 16:00. The patient underwent lab tests and procedures which included Nasal Swab: Negative on 05Jan2021. COVID tested post vaccination. No treatment received. Outcome of the event head hurting - constant achiness was not recovered.  Information about batch/lot number has been requested.
I have a huge amount of swelling in my arm pit area; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot number: EW0185, Expiration date: not reported), via an unspecified route of administration on 25Jun2021 as dose number unknown, single for Covid -19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient received the vaccine on Friday on an unspecified date and experienced a huge amount of swelling in arm pit area. The patient wanted to know if it common for people to get swelling in the arm area after the vaccine. The outcome of event was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Child has red rash like started at her neck at 8:00 Am on 9/10/2010. At 2:30 PM Child now has Red Bumps all over her body including the face. I reported to the doctor and visit the doctor at 4:30 PM. Doctor diagnosed her as having Measles. Doctor wrote a perscription and order extensive blood testing for blood count and rubella and measles. Child was taken for a blood test on 9-11-2010 at 10:00 AM and results will come in on 9/14/2010 to the doctors office. My Child has complained that after the MMR was administered she has pain on her legs she feels pain in her joins like arthritis.
Rash, itching, "flu-ish", weakness, chest tightness Pt has undocumented on profile allergy to all steroids + neomycin. Previously tolerated Fluzone HD w/o incident. Status of allergy has been added to profile. At time of vaccination pt was concerned about this and was told it wasn't in the vaccine. No mention of neomycin or steroid allergy. Pt. is extremely uncomfortable & is hoping someone will reach out to her. She was seen @ the clinic and was prescribed Atarax for rash. The nurse heard nothing in the lungs but prescribed Albuterol MDI. Pt is concerned that is now over 10 days and she still Feels "awful" when will the affects subside. We will follow up with pt on 9/29.
Lichen planus located in genital area, darkened patch of skin turning into painful sore and then forms scab and crusts.  Started approximately 6 weeks ago.   No prior history of this type of skin reaction.  Diagnosed by dermatologist as Lichen Planus.
Information has been received from a healthcare worker referring to a 24 year old male patient. On 22-APR-2015 the patient was vaccinated with a dose of GARDASIL 9, lot# not reported, 0.5 ml, intramuscularly. No adverse effects were reported. Additional information has been requested.